Mobile

plasmaMATCH: A clinical trial aiming to assess the safety and activity of targeted treatments in patients with advanced breast cancer where the targetable mutation is identified through circulating tu...

Mise à jour : Il y a 5 ans
Référence : ISRCTN16945804

plasmaMATCH: A clinical trial aiming to assess the safety and activity of targeted treatments in patients with advanced breast cancer where the targetable mutation is identified through circulating tumour DNA screening

Femme Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

Lay summary under review with external organisation

Critère d'inclusion

  • Specialty: Cancer, Primary sub-specialty: Breast Cancer; UKCRC code/ Disease: Cancer/ Malignant neoplasm of breast

Liens